The DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder
Open accessAbstract
A growing body of data suggests that hyperactivation of the immune system has been implicated in the pathophysiology of major depressive disorder (MDD). Several pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) have been found to be significantly increased in patients with MDD. This review focuses on these two cytokines based on multiple lines of evidence from genetic, animal behaviour, and clinical studies showing that altered levels of serum TNF-alpha and IL-1 are associated with increased risk of depression, cognitive impairments, and reduced responsiveness to treatment. In addition, recent findings have shown that centrally expressed TNF-alpha and IL-1 play a dual role in the regulation of synaptic plasticity. In this paper, we review and critically appraise the mechanisms by which cytokines regulate synaptic and neural plasticity, and their implications for the pathophysiology and treatment of MDD. Finally, we discuss the therapeutic potential of anti-inflammatory-based approaches for treating patients with severe mood disorders. This is a promising field for increasing our understanding of the mechanistic interaction between the immune system, synaptic plasticity, and antidepressants, and for the ultimate development of novel and improved therapeutics for severe mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the proinflammatory cytokines IL-1, IL-6, TNF-α, and IFN-γ have been implicated in neuronal development, neuroplasticity, synaptogenesis, and tissue repair[15].”
From Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? (2016) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,961
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Squire, L. R., Stark, C. E. L., & Clark, R. E. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144130 · Cited by 2,680
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Synaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Research works printed but not linked: 8
- Manji, 2001, Psychopharmacology Bulletin, 35, 5
- Zakzanis, 1998, Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 11, 111
- Bielau, 2005, European Archives of Psychiatry and Neurological Sciences, 255, 401
- 10.1002/(sici)1098-2396(200002)35:23.0.co;2-p · DOI
- 10.1210/en.132.4.1569 · DOI
- 10.1002/(sici)1097-4547(19970515)48:43.0.co;2-7 · DOI
- Li, 2007, Cellular & Molecular Immunology, 4, 407
- Kubera, 2000, Polish Journal of Pharmacology, 52, 237
Cited by
Sorted by citations
Items 101–200 of 361
Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression
Borkowska, P., Kucia, K. A., Rzeźniczek, S., Paul-Samojedny, M., Kowalczyk, M., Owczarek, A. J., Suchanek-Raif, R., Mędrala, T., & Kowalski, J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9507-5 · Cited by 56
Louzada, E. R., & Ribeiro, S. M. L. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1477349 · Cited by 55
Belge, J.-B., van Diermen, L., Sabbe, B., Parizel, P. M., Morrens, M., Coppens, V., Constant, E., de Timary, P., Sienaert, P. A., Schrijvers, D. L., et al. (2020) · Neuropsychobiology · doi:10.1159/000506133 · Cited by 55
Is there a link between TNF gene expression and cognitive deficits in depression?
Bobińska, K., Gałecka, E., Szemraj, J., Gałecki, P., & Talarowska, M. E. (1970) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1276 · Cited by 54
Ott, C. V., Johnson, C. B., Macoveanu, J., & Miskowiak, K. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.01.105 · Cited by 54
Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
Brymer, K. J., Romay-Tallón, R., Allen, J., Caruncho, H. J., & Kalynchuk, L. E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00098 · Cited by 54
Song, Z., Shen, F., Zhang, Z., Wu, S.-B., & Zhu, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108175 · Cited by 54
Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
Ghasemi, M., Phillips, C., Fahimi, A., McNerney, M. W., & Salehi, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.002 · Cited by 53
Inflamed brain: Targeting immune changes and inflammation for treatment of depression
Sakamoto, S., Zhu, X., Hasegawa, Y., Karma, S., Obayashi, M., Alway, E., & Kamiya, A. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13286 · Cited by 51
Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus
Postal, M., Peliçari, K. D. O., Sinicato, N. A., Marini, R., Costallat, L. T. L., & Appenzeller, S. (2013) · Cytokine · doi:10.1016/j.cyto.2012.11.023 · Cited by 51
Of depression and immunity: does sex matter?
Pitychoutis, P. M., & Papadopoulou‐Daifoti, Z. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000465 · Cited by 51
Liu, Y., Zhang, T., Meng, D., Sun, L., Yang, G., He, Y., & Zhang, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112371 · Cited by 51
Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine
O’Connell, K. E., Thakore, J. H., & Dev, K. K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.020 · Cited by 50
Tumour necrosis factor - alpha mediated mechanisms of cognitive dysfunction
Baune, B. T., Camara, M.-L., Eyre, H. A., Jawahar, M. C., Anscomb, H., & Körner, H. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0027-8 · Cited by 50
Cheon, Y., Lee, S., Kim, M., Kim, H. O., Suh, Y. S., Ki‐Soo, P., Kim, R. B., Yang, H.-S., Kim, J., Son, C., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.012 · Cited by 50
The role of orexin in post-stroke inflammation, cognitive decline, and depression
Song, J., Kim, E., Kim, C. H., Song, H., & Lee, J. E. (2015) · Molecular Brain · doi:10.1186/s13041-015-0106-1 · Cited by 49
Bornand, D., Toovey, S., Jick, S. S., & Meier, C. R. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.005 · Cited by 49
Mokhtari, T., & Uludağ, K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00596 · Cited by 48
Talamonti, E., Sasso, V., To, H. M., Haslam, R. P., Napier, J. A., Ulfhake, B., Pernold, K., Asadi, A., Hessa, T., Jacobsson, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901890rr · Cited by 47
Hong, W., Zhao, M., Li, H., Peng, F., Wang, F., Li, N., Xiang, H., Su, Y., Huang, Y., Zhang, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27584 · Cited by 46
Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences
Hatami, M., Abdolahi, M., Soveyd, N., Djalali, M., Togha, M., & Honarvar, N. M. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666181129103056 · Cited by 46
Depression in Parkinson's Disease: A Narrative Review
Chikatimalla, R., Dasaradhan, T., Koneti, J., Cherukuri, S. P., Kalluru, R., & Gadde, S. (2022) · Cureus · doi:10.7759/cureus.27750 · Cited by 45
Poudel‐Tandukar, K., Bertone‐Johnson, E. R., Palmer, P. H., & Poudel, K. C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.004 · Cited by 45
Stewart, A. M., Roy, S., Wong, K., Gaikwad, S., Chung, K. M., & Kalueff, A. V. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.037 · Cited by 44
Bossuyt, J., Herrewegen, Y. V. D., Nestor, L., Buckinx, A., Bundel, D. D., & Smolders, I. J. (2023) · Glia · doi:10.1002/glia.24390 · Cited by 44
Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.639800 · Cited by 44
Amorim, D., David-Pereira, A., Pertovaara, A., Almeida, A., & Pinto‐Ribeiro, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.003 · Cited by 44
Brüning, C. A., Martini, F., Soares, S. M., Savegnago, L., Sampaio, T. B., & Nogueira, C. W. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.019 · Cited by 43
Guida, F., Iannotta, M., Misso, G., Ricciardi, F., Boccella, S., Tirino, V., Falco, M., Desiderio, V., Infantino, R., Pieretti, G., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002549 · Cited by 43
Rossi, S., Motta, C., Musella, A., & Centonze, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.022 · Cited by 42
Luan, Y., Zhao, J., Yao, H., Zhao, X., Fan, R., Zhao, W., Zhang, Z., & Xu, S. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0536-8 · Cited by 42
Rábago-Monzón, Á. R., Osuna‐Ramos, J. F., Armienta-Rojas, D. A., Camberos-Barraza, J., Camacho-Zamora, A., Magaña‐Gómez, J. A., & la Herrán-Arita, A. K. D. (2025) · Biomedicines · doi:10.3390/biomedicines13051121 · Cited by 41
Ketamine: The final frontier or another depressing end?
Sial, O. K., Parise, E. M., Parise, L. F., Gnecco, T., & Bolaños‐Guzmán, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112508 · Cited by 41
Islam, M. R., Sohan, M., Daria, S., Masud, A. A., Ahmed, M. U., Roy, A., & Shahriar, M. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231198828 · Cited by 41
Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein
Petrov, B., Aldoori, A., James, C. L., Yang, K., Algorta, G. P., Lee, A., Zhang, L., Lin, T., Awadhi, R. A., Parquette, J. R., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0109-7 · Cited by 41
Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder
Ferreira, T. B., Kasahara, T. M., Barros, P. O., Vieira, M. M. M., Bittencourt, V. C. B., Hygino, J., Andrade, R. M., Linhares, U. C., Andrade, A. F., & Bento, C. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.009 · Cited by 40
De Felice, E., Gonçalves de Andrade, E., Golia, M. T., González Ibáñez, F., Khakpour, M., Di Castro, M. A., Garofalo, S., Di Pietro, E., Benatti, C., Brunello, N., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02655-z · Cited by 39
From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation
Krasner, H., Ong, C. V., Hewitt, P., & Vida, T. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073219 · Cited by 40
Ng, K.-J., Huang, K., Tung, C., Hsu, B.-B., Wu, C.-H., Lu, M., & Lai, N. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04820-x · Cited by 38
Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37
Gouda, M. H., Ali, S. M., Othman, S. S., Al-Aziz, S. A. A., Abu-Serie, M. M., Elsokary, N. A., & Elessawy, N. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00069-0 · Cited by 36
Kršek, A., Ostojić, L., Zivalj, D., & Batičić, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179695 · Cited by 36
Neuroimmunomodulation in Depression: A Review of Inflammatory Cytokines Involved in this Process
Abelaira, H. M., Réus, G. Z., Petronilho, F. C., Barichello, T., & Quevedo, J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1372-5 · Cited by 35
Effects of IL-6 and cortisol fluctuations in post-stroke depression
Zhang, X., Zou, W., & Yang, Y. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1653-0 · Cited by 35
Long-term functional recovery and compensation after cerebral ischemia in rats
Girard, S., Murray, K. N., Rothwell, N. J., Metz, G. A. S., & Allan, S. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.008 · Cited by 34
Al‐Hakeim, H. K., Al-Fadhel, S. Z., Al-Dujaili, A. H., & Maes, M. H. J. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.47 · Cited by 33
Serum IL-7 and G-CSF in major depressive disorder
Lehto, S. M., Huotari, A., NISKANEN, L. K., Herzig, K., Tolmunen, T., Viinamäki, H. T., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Sinikallio, S., Ruotsalainen, H. J., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.033 · Cited by 33
Дыгало, Н. Н., Kalinina, T. S., Bulygina, V. V., & Shishkina, G. T. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9794-y · Cited by 33
Lara-Espinosa, J. V., Santana-Martínez, R. A., Maldonado, P. D., Zetter, M. A., Becerril‐Villanueva, E., Pérez‐Sánchez, G., Pavón, L., Mata‐Espinosa, D., Barrios‐Payán, J., López-Torres, M. O., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249483 · Cited by 32
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 31
The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders
Karakuła‐Juchnowicz, H., Szachta, P., Opolska, A., Morylowska-Topolska, J., Gałęcka, M., Juchnowicz, D., Krukow, P., & Lasik, Z. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000158 · Cited by 31
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence
Tomassini, V., d’Ambrosio, A., Petsas, N., Wise, R. G., Sbardella, E., Allen, M., Tona, F., Fanelli, F., Foster, C., Carnì, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23184 · Cited by 30
Scarola, S. J., Trejo, J. R. P., Granger, M., Gerecke, K. M., & Bardi, M. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-18-000025 · Cited by 30
Early-diagnosis of major depressive disorder: From biomarkers to point-of-care testing
Zhang, X., Zhang, Z., Diao, W., Zhou, C., Song, Y., Wang, R., Luo, X., & Liu, G. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116904 · Cited by 30
Piacentini, R., & Grassi, C. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01690 · Cited by 30
Almulla, A. F., & Maes, M. H. J. (2025) · CNS Drugs · doi:10.1007/s40263-025-01195-3 · Cited by 29
Depressive-like behaviors in mice with Imiquimod-induced psoriasis
Guo, J., Liu, Y., Guo, X., Meng, Y., Qi, C., Zhao, J., Di, T., Zhang, L., Guo, X., Wang, Y., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107057 · Cited by 29
The Antidepressant-Like Effects of Shen Yuan in a Chronic Unpredictable Mild Stress Rat Model
Jiang, N., Wang, H., Huang, H. M., Lv, J., Zeng, G., Wang, Q., Bao, Y., Chen, Y., & Liu, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.622204 · Cited by 29
Panek, M., Pietras, T., Szemraj, J., & Kuna, P. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1734 · Cited by 29
Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats
Bhatt, S., Shukla, P., Raval, J., & Goswami, S. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12539 · Cited by 29
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
Debnath, M., Doyle, K., Langan, C., McDonald, C., Leonard, B., & Cannon, D. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0019-0 · Cited by 28
Cavalu, S. D., Saber, S., Ramadan, A., Elmorsy, E. A., Hamad, R. S., Abdel‐Reheim, M. A., & Youssef, M. E. (2024) · The FASEB Journal · doi:10.1096/fj.202400823r · Cited by 28
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
Henter, I. D., SOUSA, R. T. D., Gold, P. W., Brunoni, A. R., Zarate, C. A., & Machado‐Vieira, R. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1253472 · Cited by 29
Self-citationInflammation as a Mechanism of Bipolar Disorder Neuroprogression
Barichello, T., Giridharan, V. V., Bhatti, G. S., Sayana, P., Doifode, T., Macêdo, D. S., & Quevedo, J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_173 · Cited by 28
Alterations in circulating extracellular vesicles underlie social stress‐induced behaviors in mice
Sakamoto, S., Mallah, D., Medeiros, D., Dohi, E., Imai, T., Rose, I. V. L., Matoba, K., Zhu, X., Kamiya, A., & Kano, S. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13204 · Cited by 27
Yndart, A., Kaushik, A. K., Agudelo, M., Raymond, A., Atluri, V. S. R., Saxena, S. K., & Nair, M. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00156 · Cited by 27
Wu, Y. H., Li, Y., Jia, Y., Wei, C., Xu, H., Guo, R. H., Li, Y., Jia, J., Qi, X., & Gao, X. (2017) · Molecular BioSystems · doi:10.1039/c7mb00494j · Cited by 27
Andy, S. N., Pandy, V., Alias, Z., & Kadir, H. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.035 · Cited by 27
Biologically flavored perspectives on Garmezian resilience
Hanson, D. R., & Gottesman, I. I. (2012) · Development and Psychopathology · doi:10.1017/s0954579412000041 · Cited by 26
do Nascimento, F. P., Macedo-Júnior, S. J., Borges, F. R. M., Cremonese, R. P., da Silva, M. D., Cerutti, M. L., Martins, D. F., Rodrigues, A. L. S., & Santos, A. R. S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.044 · Cited by 26
Naeini, F. B., Hassanpour, S., & Asghari, A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114201 · Cited by 25
Gureev, A. P., Khorolskaya, V. G., Sadovnikova, I. S., Shaforostova, E. A., Cherednichenko, V. R., Burakova, I. Y., Plotnikov, E. Y., & Popov, V. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315197 · Cited by 25
Abdi, I. Y., Bartl, M., Dakna, M., Abdesselem, H., Majbour, N. K., Trenkwalder, C., El‐Agnaf, O. M. A., & Mollenhauer, B. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.105997 · Cited by 26
Fang, Z., Zhou, Y., Chen, K. G., Wang, J., Liu, X., & Jia, P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1587818 · Cited by 24
Linking Environmental Exposures to Depression: Insights from Epidemiology, Biology, and Methodology
Zhang, Z., Zhao, Q., Xu, J., Yang, K., Wu, Y., Lei, M., Wu, Q., Wang, H., Cai, W., An, Q., et al. (2025) · Brain Conflux · doi:10.71321/ymyc0370 · Cited by 24
The involvement of neuroinflammation in an animal model of dementia and depression
Zabot, G. C., Medeiros, E. B., Macarini, B. M. N., Peruchi, B. B., Keller, G. S., Lídio, A. V., Boaventura, A. L., de Jesus, L. C., Silveira, G. D. B., Silveira, P. C. L., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110999 · Cited by 24
Supraspinal Mechanisms of Intestinal Hypersensitivity
Любашина, О. А., Sivachenko, I. B., & Panteleev, S. S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00967-3 · Cited by 24
Orphanin FQ/Nociceptin Activates Nuclear Factor Kappa B
Donica, C. L., Ramirez, V. I., Awwad, H. O., Zaveri, N. T., Toll, L., & Standifer, K. M. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9279-2 · Cited by 24
Wei, Z., Yao, M., Li, Y., He, X., & Yang, Z. (2014) · Inflammation · doi:10.1007/s10753-014-9925-y · Cited by 24
Himmerich, H., Keeler, J. L., King, J. A., Ehrlich, S., Kaufmann, L., Bulik, C. M., Cohen‐Woods, S., Wade, T. D., Steiger, H., Booij, L., et al. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2626934 · Cited by 24
Wang, J., Wang, Y., Chen, Y., Zhang, J., Zhang, Y., Li, S., Zhu, H., Song, X., Hou, L., Wang, L., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04438-4 · Cited by 23
Sorri, A., Järventausta, K., Kampman, O., Lehtimäki, K. A., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., & Leinonen, E. V. J. (2018) · Brain and Behavior · doi:10.1002/brb3.933 · Cited by 23
Basta‐Kaim, A., Ślusarczyk, J., Szczepanowicz, K., Warszyński, P., Leśkiewicz, M., Regulska, M., Trojan, E., & Lasoń, W. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.02.017 · Cited by 22
Ma, H., Wang, Y., Xue, Y., Huang, D., Kong, Y.-J., Zhao, X., & Zhang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108639 · Cited by 22
Cremone, I. M., Nardi, B., Amatori, G., Palego, L., Baroni, D., Casagrande, D., Massimetti, E., Betti, L., Giannaccini, G., Dell’Osso, L., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061600 · Cited by 21
Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level
Belge, J.-B., Mulders, P. C. R., van Diermen, L., Sienaert, P. A., Sabbe, B., Abbott, C., Tendolkar, I., Schrijvers, D. L., & van Eijndhoven, P. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110809 · Cited by 21
Remali, J., & Aizat, W. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38986 · Cited by 21
Khan, H., Naseem, T., Kaushik, P., Narang, J., Khan, R., Panwar, S., & Parvez, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102535 · Cited by 21
Raoof, M., Esmaeili‐Mahani, S., Nourzadeh, M., Raoof, R., Abbasnejad, M., Amirkhosravi, L., Hajializadeh, Z., Haghani, J., & Rafie, F. (2015) · Journal of Oral & Facial Pain and Headache · doi:10.11607/ofph.1452 · Cited by 21
Emotion-on-a-chip (EOC): Evolution of biochip technology to measure human emotion using body fluids
Lee, J.-H., Hwang, Y., Cheon, K.-A., & Jung, H.-I. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.09.002 · Cited by 20
Behavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 20
Self-citationVizuete, A. F. K., Mussulini, B. H. M., Zenki, K. C., Baggio, S., Pasqualotto, A., Rosemberg, D. B., Bogo, M. R., de Oliveira, D. L., & Rico, E. P. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.10.014 · Cited by 19
Qian, X., Zhong, Z.-D., Zhang, Y., Qiu, L., & Tan, H.-J. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148723 · Cited by 19
Dutheil, S., Watson, L. S., Davis, R. E., & Snyder, G. L. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0984-22.2022 · Cited by 19
Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases
Shie, F., Chen, Y., Chen, C., & Ho, I.-K. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9241-8 · Cited by 19
Immunological Interfaces: The COVID-19 Pandemic and Depression
Perlmutter, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.657004 · Cited by 18
Targeting Endocannabinoid System in Epilepsy: For Good or for Bad
Martínez-Aguirre, C., Çınar, R., & Rocha, L. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.013 · Cited by 18
Sangma, J. T., & Trivedi, A. K. (2023) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-023-00451-z · Cited by 18
Depression and altered serum lipids in cynomolgus monkeys consuming a Western diet
Chilton, F. H., Lee, T. C., Willard, S. L., Ivester, P., Sergeant, S., Register, T. C., & Shively, C. A. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.01.013 · Cited by 18
Machado‐Vieira, R. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1062 · Cited by 17
Self-citation
Metadata
- Authors
- Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-19
- Volume
- 12
- Issue
- 04
- Pages
- 561
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC2771334
- OpenAlex
- W2164978865
- Cited by
- 350
- References
- 212
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 22 · 2023: 25 · 2022: 18 · 2021: 29 · 2020: 22 · 2019: 23 · 2018: 17 · 2017: 20 · 2016: 20 · 2015: 19 · 2014: 27 · 2013: 14 · 2012: 23
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute of Mental Health (Z01MH002835)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- major depressive disorder, inflammatory cytokines, synaptic plasticity, TNF-α, interleukin-1, neuroinflammation, cognitive impairment, treatment resistance, anti-inflammatory therapy, antidepressants
- MeSH terms
- Animals, Antidepressive Agents, Brain Chemistry, Depressive Disorder, Major, Major Depressive Disorder, Humans, Neuronal Plasticity, Cytokines, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
